Dermatological Therapeutics Market 2019-2024: Worldwide Growth, Trends, and Forecast Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Dermatological
Therapeutics Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The dermatological therapeutics market is expected to register a CAGR of
7%, during the forecast period.

With rising number of elderly population, dermatology care is likely to
receive particular attention. As people age, their risk of developing
skin-related disorders increase, due to factors, such as changes in the
connective tissue, reduction in the skin’s strength and elasticity, and
reduction in secretions from sebaceous glands. The increasing incidence
of dermatological diseases and increasing levels of awareness-related
disease progression, etiology, and available therapies are leading to
high growth of dermatological therapeutics.

By Application, Acne Vulgaris is the Largest segment; Atopic
Dermatitis is Expected to Register Robust Growth

Acne therapeutics is the largest market segment of the dermatological
diagnostics market, accounting for nearly 30% of the total revenue. The
high prevalence rates of acne, coupled with the availability of
over-the-counter therapeutics, leads to large market size. According to
the Global Burden of Disease (GBD) study, acne vulgaris affects nearly
85% of young adults aged between 12-25 years.

Atopic dermatitis is a widespread chronic inflammatory skin condition
that can affect patients of all ages, and is the result of multiple
environmental, immunological, genetic, and pharmacologic factors. The
disease mostly flares up when the patient is around the things that
cause allergic reactions. The malfunctioning in the immune system of the
human body, due to asthma, is also a major causes for atopic dermatitis.
Due to several lifestyle factors, the global burden of atopic dermatitis
is increasing rapidly, which is, in turn, fueling the growth of the
segment.

North America Dominates the Market, in Terms of Revenue, and
Asia-Pacific is Expected to Register Rapid Growth

North America is expected to lead the global market. Increasing
healthcare expenditure, awareness about skin diseases, and strong
presence of pharmaceutical companies are anticipated to drive the growth
of the market in North America. In the Asia-Pacific region, the
ever-increasing pool of the patient population, increasing awareness,
and increasing disposable incomes are expected to be pivotal to the
robust market growth in the region.

Competitive Landscape

Many new players are emerging in this market, as a result of a number of
growth opportunities. Forthcoming patent expiries of major drugs are
leading to increased competition, and is further driving the market,
especially in the generic sector. The overall dermatological diagnostics
and therapeutics industry is forecast to witness tremendous growth, with
several generic players controlling significant market share in the
developing regions.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increase in Incidence Rates of Dermatology Diseases

4.2.2 Increase in Awareness Levels of Disease Progression and Etiology

4.2.3 Increase in the Elderly Population

4.3 Market Restraints

4.3.1 Serious Side Effects for Certain Classes of Therapeutic Drugs

4.4 Porter’s Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Application

5.1.1 Alopecia

5.1.2 Herpes

5.1.3 Psoriasis

5.1.4 Rosacea

5.1.5 Atopic Dermatitis

5.1.6 Acne Vulgaris

5.1.7 Other Applications

5.2 By Drug Class

5.2.1 Anti-infectives

5.2.2 Corticosteroids

5.2.3 Anti-acne

5.2.4 Calcineurin Inhibitors

5.2.5 Retinoids

5.2.6 Other Drug Classes

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 AGI Dermatics

6.1.2 Allergan Inc

6.1.3 Amgen Inc.

6.1.4 Chester Valley Pharmaceuticals Inc.

6.1.5 Dermik Laboratories Inc.

6.1.6 Eisai Inc.

6.1.7 Ferndale Laboratories Inc.

6.1.8 Genentech Inc.

6.1.9 Medicis Pharmaceutical Corp. (Bausch Health)

6.1.10 Onset Therapeutics

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/ejm2zf

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Dermatological
Drugs